Side-by-side comparison of AI visibility scores, market position, and capabilities
Ambience Healthcare raised $370M (~$1B valuation) and hit $30M ARR with ambient AI documentation across 100+ specialties, eliminating the documentation burden driving clinician burnout.
Ambience Healthcare was founded in 2020 in San Francisco with a mission to eliminate the documentation burden that drives clinician burnout and degrades patient care quality across health systems. The company builds ambient AI documentation technology that listens to clinical encounters across more than 100 medical and surgical specialties, generating accurate, complete clinical notes in the background without requiring clinicians to dictate or type. Ambience's core technology leverages large language models purpose-trained on clinical language, specialty-specific note structures, and electronic health record formatting requirements to produce documentation that is ready for review with minimal editing.\n\nAmbience's platform is deployed across health systems ranging from large academic medical centers to independent practices, covering more than 100 specialties including primary care, surgery, oncology, behavioral health, and pediatrics. Unlike narrower documentation tools that focus on a single specialty or encounter type, Ambience's breadth allows health systems to deploy a single solution enterprise-wide. The platform integrates with major EHR systems including Epic and Cerner, embedding documentation into existing clinical workflows without requiring behavior change from clinicians. Ambience achieved approximately $30 million in annual recurring revenue as of May 2025.\n\nAmbience Healthcare has raised approximately $370 million in total funding, approaching a $1 billion valuation, from investors including Andreessen Horowitz and other leading healthcare-focused venture firms. The company competes with Nuance DAX, Suki, and Nabla in the ambient documentation space but differentiates through its specialty breadth, enterprise EHR integration depth, and strong health system relationships. As health systems face escalating clinician burnout and documentation-driven inefficiency, Ambience's full-enterprise approach positions it as a platform of record for ambient clinical intelligence.
Franklin Lakes NJ medical technology (NYSE: BDX) at $21.8B FY2025 revenue (+8.2%); $17.5B Reverse Morris Trust spinoff with Waters (2025), Edwards critical care acquisition $4.2B (2024) competing with Baxter for infusion systems.
Becton, Dickinson and Company (BD) is a Franklin Lakes, New Jersey-based global medical technology company — publicly traded on the New York Stock Exchange (NYSE: BDX) as an S&P 500 Health Care component — manufacturing and selling medical supplies, devices, laboratory equipment, and diagnostic products through approximately 74,000 employees serving healthcare institutions, clinical laboratories, pharmaceutical companies, and life science researchers in over 190 countries. In fiscal year 2025 (ended September 30, 2025), BD reported full-year revenue of $21.8 billion (up 8.2% year-over-year) with Q4 FY2025 revenue of $5.9 billion (+8.3% reported, +3.9% organic growth), and declared a quarterly dividend of $1.05 per share (+1%). Founded in 1897 in New York City by Maxwell Becton and Fairleigh Dickinson Sr. as a thermometer and surgical instrument maker, BD has grown through 125+ years of acquisitions to become a Fortune 500 ($21.8B revenue, #211 on 2024 Fortune 500) global medtech leader. The company operates through three segments: BD Medical (~50% of revenue, IV catheters, syringes, prefillable drug delivery systems, and medication management solutions), BD Life Sciences (flow cytometry, microbiology, molecular diagnostics, and lab automation), and BD Interventional (advanced patient monitoring, interventional cardiology, and peripheral vascular interventions). BD invests $1.2+ billion annually in R&D. In 2024, BD acquired Edwards Lifesciences' critical care monitoring unit for $4.2 billion.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.